SECOND OPINION | CROHN'S DISEASE | BCBS | Full Episode
Since the age 12, Gabi Thomas has been fighting the physical and mental ramifications of having Crohn’s Disease. She explains her challenges over the last 15 years, which culminated in several hospital stays and being on the brink of death. While experts discuss current treatments for Crohn’s, Gabi shares her journey of healing; explaining why she has never felt better.
Visit http://www.SecondOpinion-TV.org
Funded by Blue Cross Blue Shield Association: http://www.bcbs.com/
Видео SECOND OPINION | CROHN'S DISEASE | BCBS | Full Episode канала Second Opinion with Joan Lunden
Visit http://www.SecondOpinion-TV.org
Funded by Blue Cross Blue Shield Association: http://www.bcbs.com/
Видео SECOND OPINION | CROHN'S DISEASE | BCBS | Full Episode канала Second Opinion with Joan Lunden
Показать
Комментарии отсутствуют
Информация о видео
6 ноября 2017 г. 21:57:09
00:25:35
Другие видео канала
SECOND OPINION | IBS | Full EpisodeLiving With Crohn’s Disease: 1 Woman Shares Her Struggle | TODAY OriginalSECOND OPINION | LUPUS | BCBS | Full EpisodeAre we getting closer to curing inflammatory bowel diseases?On Tour with Crohn's Disease | Newsbeat DocumentariesNutrition for IBD (Crohn's and Colitis) Featuring Anne-Marie Stelluti | GI SocietySECOND OPINION | Reversing Heart Disease Episode | BCBSSECOND OPINION | Shingles | APT | Full EpisodeDane Johnson | Naturally Healing Crohns and ColitisFecal Microbial Transformation: Diet as Therapy in IBDSECOND OPINION | HYPOTHYROIDISM | BCBS | Full EpisodeTEDxEast - Ari Meisel Beats Crohn's DiseaseWoman Gets Colon Removed After Crohn’s Disease Worsens | TodaySECOND OPINION | BORDERLINE PERSONALITY DISORDER | BCBS | Full EpisodeMy Crohn's Disease Journey | Paige Joanna STORY TIMECases: Mucosal Healing in Moderate-to-Severe Crohn’s DiseaseSan Diego Health: Inflammatory Bowel Disease Causes, Symptoms and TreatmentSECOND OPINION | Ovarian Cancer | APT | Full EpisodeSECOND OPINION WITH JOAN LUNDEN | PARKINSON'S DISEASE | BCBS | Full EpisodeUpdate on vedolizumab in IBD: What have we learned?